Wenpan Li

1.0k total citations
38 papers, 753 citations indexed

About

Wenpan Li is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Wenpan Li has authored 38 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Biomaterials and 12 papers in Biomedical Engineering. Recurrent topics in Wenpan Li's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (13 papers) and Nanoplatforms for cancer theranostics (12 papers). Wenpan Li is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (13 papers) and Nanoplatforms for cancer theranostics (12 papers). Wenpan Li collaborates with scholars based in China, United States and Hong Kong. Wenpan Li's co-authors include Dawei Chen, Haiyang Hu, Jianqin Lu, Zhiren Wang, Jiulong Zhang, Xiuli Zhao, Mingxi Qiao, Jonghan Park, Shilong Hao and Wenjie Zhang and has published in prestigious journals such as Nature Communications, Environmental Science & Technology and Biomaterials.

In The Last Decade

Wenpan Li

35 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenpan Li China 18 267 254 225 160 117 38 753
Yongheng Wang China 17 293 1.1× 464 1.8× 226 1.0× 66 0.4× 91 0.8× 39 1.2k
Kevin S. Chu United States 13 333 1.2× 267 1.1× 350 1.6× 38 0.2× 58 0.5× 15 977
Yuan Qian China 18 521 2.0× 475 1.9× 235 1.0× 427 2.7× 211 1.8× 36 1.4k
Zitong Zhao China 16 295 1.1× 283 1.1× 141 0.6× 227 1.4× 115 1.0× 36 767
Reza Shahbazi Iran 15 250 0.9× 271 1.1× 225 1.0× 31 0.2× 68 0.6× 39 798
Hongjuan Zeng China 18 374 1.4× 277 1.1× 116 0.5× 33 0.2× 87 0.7× 53 1.0k
Tao Deng China 20 469 1.8× 243 1.0× 178 0.8× 79 0.5× 39 0.3× 53 1.0k
Hongyi Chen China 15 398 1.5× 533 2.1× 169 0.8× 254 1.6× 169 1.4× 32 1.2k

Countries citing papers authored by Wenpan Li

Since Specialization
Citations

This map shows the geographic impact of Wenpan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenpan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenpan Li more than expected).

Fields of papers citing papers by Wenpan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenpan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenpan Li. The network helps show where Wenpan Li may publish in the future.

Co-authorship network of co-authors of Wenpan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wenpan Li. A scholar is included among the top collaborators of Wenpan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenpan Li. Wenpan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Shilong, et al.. (2025). Using multiple machine learning algorithms to optimize the water quality index model and their applicability. Ecological Indicators. 172. 113299–113299. 6 indexed citations
2.
Wang, Zhiren, Wenpan Li, Teng Ma, et al.. (2025). Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32. Acta Biomaterialia. 200. 629–640.
4.
Yuan, Hao Bin, et al.. (2025). Optimization of graph wavenet model for dissolved oxygen prediction using self-distillation and whale optimization algorithm. Journal of Water Process Engineering. 75. 108013–108013. 2 indexed citations
5.
Li, Mengwen, et al.. (2025). Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines. Nano Research. 18(7). 94907534–94907534.
6.
Wang, Qi, et al.. (2024). Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment. Advanced Healthcare Materials. 13(20). e2400219–e2400219. 8 indexed citations
7.
Wang, Zhiren, et al.. (2024). Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature Communications. 15(1). 2073–2073. 24 indexed citations
8.
Wang, Zhiren, et al.. (2024). Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy. Biomaterials. 306. 122477–122477. 9 indexed citations
9.
Li, Wenpan, et al.. (2023). Lipid-Based Nanotechnology: Liposome. Pharmaceutics. 16(1). 34–34. 51 indexed citations
10.
11.
Zhao, Chaoyue, et al.. (2022). Multi-functional platelet membrane-camouflaged nanoparticles reduce neuronal apoptosis and regulate microglial phenotype during ischemic injury. Applied Materials Today. 27. 101412–101412. 21 indexed citations
12.
Li, Wenpan, et al.. (2022). Surface-modified nanotherapeutics targeting atherosclerosis. Biomaterials Science. 10(19). 5459–5471. 14 indexed citations
13.
Wang, Zhiren, et al.. (2022). Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. Journal of Controlled Release. 349. 929–939. 40 indexed citations
14.
Li, Wenpan, et al.. (2021). Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Molecular Pharmaceutics. 18(8). 2889–2905. 28 indexed citations
15.
Huang, Ziyuan, Yuying Chen, Jiulong Zhang, et al.. (2021). Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. ACS Applied Materials & Interfaces. 13(33). 39934–39948. 41 indexed citations
16.
Jia, Nan, Xirui Zhang, Wenpan Li, Dawei Chen, & Haiyang Hu. (2020). Phospholipid-Coated Guanosine Diphosphate Auxiliary CaP Active Nanoparticles Can Systematically Improve the Efficiency of Gene Therapy for Cancer Disease. ACS Biomaterials Science & Engineering. 6(4). 2107–2116. 4 indexed citations
17.
Jia, Nan, et al.. (2020). Tumor Microenvironment Stimuli-Responsive Nanoparticles for Programmed Anticancer Drug Delivery. Molecular Pharmaceutics. 17(5). 1516–1526. 41 indexed citations
18.
Chen, Kang, Xiu Xin, Lipeng Qiu, et al.. (2019). Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy. Acta Biomaterialia. 100. 118–131. 18 indexed citations
19.
Li, Wenpan, Jia Fu, Dan Liu, et al.. (2019). Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency. Acta Biomaterialia. 96. 456–467. 26 indexed citations
20.
Li, Wenpan, Xirui Zhang, Xiu Xin, et al.. (2017). Preparation of Calcium Phosphate/pDNA Nanoparticles for Exogenous Gene Delivery by Co-Precipitation Method: Optimization of Formulation Variables Using Box-Behnken Design. Journal of Pharmaceutical Sciences. 106(8). 2053–2059. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026